Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
apolipoprotein B | 0.453 | 0.808 | 1.9E-16 |
|
disease | 0.200 | None | 0.971 | 1 | 0 | 1985 | 2019 | ||||||||
|
microsomal triglyceride transfer protein | 0.505 | 0.846 | 1.0E-05 |
|
disease | 0.800 | None | 0.982 | 1 | 0 | 1985 | 2019 | ||||||||
|
coagulation factor V | 0.441 | 0.846 | 5.9E-15 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2005 | 2007 | ||||||||
|
coagulation factor II, thrombin | 0.415 | 0.885 | 1.1E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
major histocompatibility complex, class I, G | 0.461 | 0.769 | 1.4E-11 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
synaptonemal complex protein 3 | 0.663 | 0.385 | 9.2E-05 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
coagulation factor V | 0.441 | 0.846 | 5.9E-15 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2005 | 2007 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2007 | 2007 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
metallothionein 3 | 0.582 | 0.615 | 6.4E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2001 | 2005 | ||||||||
|
betaine--homocysteine S-methyltransferase | 0.595 | 0.731 | 3.7E-14 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
solute carrier family 19 member 1 | 0.523 | 0.692 | 6.5E-06 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
nestin | 0.450 | 0.808 | 1.6E-06 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
nucleotide binding oligomerization domain containing 2 | 0.423 | 0.923 | 2.0E-30 |
|
phenotype | 0.020 | None | 0.500 | 1 | 0 | 2008 | 2010 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit beta3 | 0.546 | 0.615 | 0.95 |
|
disease | 0.500 | None | 0.917 | 2 | 0 | 1999 | 2019 | ||||||||
|
calcium voltage-gated channel subunit alpha1 H | 0.628 | 0.423 | 4.8E-10 |
|
disease | 0.500 | None | 1.000 | 2 | 0 | 2003 | 2020 | ||||||||
|
chloride voltage-gated channel 2 | 0.626 | 0.462 | 5.5E-12 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
leucine rich repeat LGI family member 4 | 0.678 | 0.308 | 7.2E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
early growth response 1 | 0.433 | 0.923 | 0.35 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
CLN8 transmembrane ER and ERGIC protein | 0.682 | 0.423 | 3.6E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
gamma-aminobutyric acid type B receptor subunit 1 | 0.587 | 0.769 | 1.00 |
|
disease | 0.020 | None | 0.500 | 1 | 0 | 2003 | 2007 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit gamma2 | 0.548 | 0.654 | 0.74 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2019 |